Evofem Biosciences, Inc.
EVFM- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001618835
No open-market purchases or sales by Evofem Biosciences, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Evofem Biosciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 0 | 1 | +1 |
| Shares | 0 | 1 | +1 |
| Value | $0 | $0 | $0 |
New holders (1)
Institutions that held Evofem Biosciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bessemer Group Inc | 1 | $0 | 0.00% |
Sold out (0)
Institutions that held Evofem Biosciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.